BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8399394)

  • 1. Purification and characterization of deoxycytidine kinase from acute myeloid leukemia cell mitochondria.
    Wang LM; Kucera GL; Capizzi RL
    Biochim Biophys Acta; 1993 Oct; 1202(2):309-16. PubMed ID: 8399394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of purine deoxyribonucleoside kinases from human leukemia cells: substrate activation by purine and pyrimidine deoxyribonucleosides.
    Sarup JC; Fridland A
    Biochemistry; 1987 Jan; 26(2):590-7. PubMed ID: 3030413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human deoxythymidine kinase II: substrate specificity and kinetic behavior of the cytoplasmic and mitochondrial isozymes derived from blast cells of acute myelocytic leukemia.
    Lee LS; Cheng Yc
    Biochemistry; 1976 Aug; 15(17):3686-90. PubMed ID: 1066165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deoxycytidine kinase from human leukemic spleen: preparation and characteristics of homogeneous enzyme.
    Bohman C; Eriksson S
    Biochemistry; 1988 Jun; 27(12):4258-65. PubMed ID: 2844225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A critical role for uridine nucleotides in the regulation of deoxycytidine kinase and the concentration dependence of 1-beta-D-arabinofuranosylcytosine phosphorylation in human leukemia cells.
    White JC; Capizzi RL
    Cancer Res; 1991 May; 51(10):2559-65. PubMed ID: 2021937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substrate-specific deoxycytidine kinase deficiency in 1-beta-D-arabinofuranosylcytosine-resistant leukemic cells.
    Richel DJ; Colly LP; Arkesteijn GJ; Arentsen-Honders MW; Kerster MG; ter Riet PM; Willemze R
    Cancer Res; 1990 Oct; 50(20):6515-9. PubMed ID: 2208110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human T-lymphoblast deoxycytidine kinase: purification and properties.
    Datta NS; Shewach DS; Hurley MC; Mitchell BS; Fox IH
    Biochemistry; 1989 Jan; 28(1):114-23. PubMed ID: 2539852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human deoxycytidine kinase. Purification and characterization of the cytoplasmic and mitochondrial isozymes derived from blast cells of acute myelocytic leukemia patients.
    Cheng YC; Domin B; Lee LS
    Biochim Biophys Acta; 1977 Apr; 481(2):481-92. PubMed ID: 265735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism and chemotherapeutic activity of 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia L1210 and evidence for its phosphorylation by deoxycytidine kinase.
    Brockman RW; Cheng YC; Schabel FM; Montgomery JA
    Cancer Res; 1980 Oct; 40(10):3610-5. PubMed ID: 6254636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct photoaffinity-labelling of human deoxycytidine kinase with the feedback inhibitor dCTP.
    Jansson O; Eriksson S
    Biochem J; 1990 Jul; 269(1):201-5. PubMed ID: 2165395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of high salt concentrations on the regulation of the substrate specificity of human recombinant deoxycytidine kinase.
    Usova EV; Eriksson S
    Eur J Biochem; 1997 Sep; 248(3):762-6. PubMed ID: 9342227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleotide specificity of human deoxycytidine kinase.
    Shewach DS; Reynolds KK; Hertel L
    Mol Pharmacol; 1992 Sep; 42(3):518-24. PubMed ID: 1406603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic analysis of human deoxycytidine kinase with the true phosphate donor uridine triphosphate.
    Hughes TL; Hahn TM; Reynolds KK; Shewach DS
    Biochemistry; 1997 Jun; 36(24):7540-7. PubMed ID: 9200705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Affinity purification of human deoxycytidine kinase: avoidance of structural and kinetic artifacts arising from limited proteolysis.
    Kim MY; Ikeda S; Ives DH
    Biochem Biophys Res Commun; 1988 Oct; 156(1):92-8. PubMed ID: 2845988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deoxycytidine kinase is phosphorylated in vitro by protein kinase C alpha.
    Wang LM; Kucera GL
    Biochim Biophys Acta; 1994 Nov; 1224(2):161-7. PubMed ID: 7981228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deoxyadenosine/deoxycytidine kinase from Bacillus subtilis. Purification, characterization, and physiological function.
    Møllgaard H
    J Biol Chem; 1980 Sep; 255(17):8216-20. PubMed ID: 6251049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arabinosylguanine is phosphorylated by both cytoplasmic deoxycytidine kinase and mitochondrial deoxyguanosine kinase.
    Rodriguez CO; Mitchell BS; Ayres M; Eriksson S; Gandhi V
    Cancer Res; 2002 Jun; 62(11):3100-5. PubMed ID: 12036920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversible permeabilization of lymphocytes destroys the incorporation of deoxythymidine but not of deoxycytidine.
    Taljanidisz J; Sasvari-Szekely M; Spasokutotskaja T; Antoni F; Staub M
    Biochim Biophys Acta; 1986 Mar; 885(3):266-71. PubMed ID: 3947681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential affinities of pyrimidine nucleoside analogues for deoxythymidine and deoxycytidine kinase determine their incorporation into murine leukemia L1210 cells.
    Balzarini J; De Clercq E
    Acta Biochim Pol; 1987; 34(2):63-77. PubMed ID: 2823514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of deoxycytidine on the in vitro response of human leukemia cells to inhibitors of de novo pyrimidine biosynthesis.
    Bhalla K; Grant S
    Cancer Chemother Pharmacol; 1987; 19(3):226-32. PubMed ID: 3581416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.